Filter News
Area of Research
- (-) Computational Engineering (1)
- (-) Isotopes (6)
- Advanced Manufacturing (8)
- Biological Systems (1)
- Biology and Environment (56)
- Building Technologies (2)
- Clean Energy (161)
- Computational Biology (2)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Energy Sciences (2)
- Functional Materials for Energy (2)
- Fusion and Fission (28)
- Fusion Energy (13)
- Materials (88)
- Materials for Computing (13)
- National Security (13)
- Neutron Science (105)
- Nuclear Science and Technology (16)
- Quantum information Science (1)
- Supercomputing (74)
- Transportation Systems (2)
News Topics
- (-) Biomedical (6)
- (-) Energy Storage (1)
- (-) Summit (1)
- Artificial Intelligence (1)
- Big Data (1)
- Clean Water (1)
- Climate Change (2)
- Computer Science (4)
- Environment (2)
- High-Performance Computing (1)
- Irradiation (1)
- Isotopes (24)
- Machine Learning (1)
- Materials (4)
- Materials Science (2)
- Mathematics (1)
- National Security (1)
- Nuclear Energy (3)
- Security (1)
- Space Exploration (4)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Oak Ridge National Laboratory scientists recently demonstrated a low-temperature, safe route to purifying molten chloride salts that minimizes their ability to corrode metals. This method could make the salts useful for storing energy generated from the sun’s heat.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.